Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 11

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 11
---
 as of November 8, 2024, by and between CERo and Keystone. “ Old Keystone Purchase Agreement” refers to the Common Stock Purchase Agreement, dated as of February 14, 2024, by and between PBAX and Keystone. “ Old Keystone Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of February 14, 2024, by and between CERo and Keystone. “ PBAX”refers to Phoenix Biotech Acquisition Corp., a Delaware corporation. “ PBAX Class A Common Stock” refers to the Class A common stock, par value $0.0001 per share, of PBAX. “ PIPE Financings” refers to the First PIPE Financing, the Second PIPE Financing and the Third PIPE Financing. “ PIPE Investors” refer to the investors in the PIPE Financings. “ PIPE Registration Rights Agreement” refers to the First PIPE Registration Rights Agreement, the Second PIPE Registration Rights Agreement and the Third PIPE Registration Rights Agreement. “ PIPE Warrants” refer to the Series A Warrants, the Series C Warrants and the Preferred Warrants issued in the PIPE Financings. “ Preferred Stock” refers to the shares of preferred stock, par value $0.0001 per share, of CERo. “Preferred Shares” refer to the shares of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock issued in the PIPE Financings, including the Warrant Preferred Shares. “ Preferred Warrants” refer to warrants to purchase shares of Series A Preferred Stock. “ Primary Earnout Shares” refer to the 12,000 shares of Common Stock issued to the holders of Legacy CERo common stock and Legacy CERo preferred stock in connection with the Business Combination, 10,000 of which are subject to vesting upon the achievement of certain stock price-based earnout targets and 2,000 of which are subject to vesting upon a change of control, respectively. vii “ Private Placement Warrants” refer to private placement warrants to purchase shares of Common Stock, at an exercise price of $1,150.00 per share, that were originally sold in a private placement concurrently with the Initial Public Offering. “ Public Warrants” refer to the warrants to purchase shares of Common Stock, at an exercise price of $1,150.00 per share, that were originally issued in the Initial Public Offering. “ Rollover Warrants” refer to warrants to purchase shares of Common Stock, at an exercise price of $1,000